These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796 [TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. Lin WC; Wong JM; Tung CC; Lin CP; Chou JW; Wang HY; Shieh MJ; Chang CH; Liu HH; Wei SC; World J Gastroenterol; 2015 Dec; 21(48):13566-73. PubMed ID: 26730169 [TBL] [Abstract][Full Text] [Related]
14. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission. Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215 [TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461 [TBL] [Abstract][Full Text] [Related]
16. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813 [TBL] [Abstract][Full Text] [Related]
17. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation. Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878 [TBL] [Abstract][Full Text] [Related]
18. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound. Orlando A; Modesto I; Castiglione F; Scala L; Scimeca D; Rispo A; Teresi S; Mocciaro F; Criscuoli V; Marrone C; Platania P; De Falco T; Maisano S; Nicoli N; Cottone M Eur Rev Med Pharmacol Sci; 2006; 10(1):17-22. PubMed ID: 16494106 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660 [TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]